Venker Eric
SEC CIK 1801917 · EDGAR
BoughtSold
Most active insiders at ROIV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MANCHESTER KEITH S | Dir | — | $154.47M |
| 2 | Gold Daniel Allen | Dir | — | $147.38M |
| 3 | QVT Financial LP | Dir by Deputization | — | $147.38M |
| 4 | Sukhatme Mayukh | Pres, CIO, Dir | — | $109.13M |
| 5 | Ramaswamy Vivek | 10% | — | $105.88M |
| 6 | Venker Eric | Pres, Immunovant CEO | — | $89.77M |
| 7 | Torti Frank | Pres, Vant COB | — | $82.04M |
| 8 | Gline Matthew | CEO, Dir | — | $46.17M |
| 9 | Pulik Richard | CFO | — | $9.12M |
| 10 | Fitzgerald Meghan | Dir | — | $3.27M |
Transactions 148
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-12 | 2023-09-08 | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | S - Sale+OE | $12.19 | -106.4K | 611.8K | -15% | -$1.30M |
| DM | 2023-09-06 | 2023-09-01+ | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | S - Sale+OE | $11.91 | -94.0K | 611.8K | -13% | -$1.12M |
| DM | 2023-09-06 | 2023-09-01+ | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | M - OptEx | $3.85 | +94.0K | 626.6K | +18% | +$361.8K |
| 2023-08-24 | 2023-08-22 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $10.83 | -16.1K | 611.8K | -3% | -$174.4K | |
| D | 2023-08-16 | 2023-08-14 | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | S - Sale+OE | $11.89 | -59.8K | 627.9K | -9% | -$711.2K |
| D | 2023-08-16 | 2023-08-14 | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | M - OptEx | $3.85 | +59.8K | 687.7K | +10% | +$230.3K |
| D | 2023-08-07 | 2023-08-03 | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | M - OptEx | $3.85 | +44.6K | 672.5K | +7% | +$171.8K |
| D | 2023-08-07 | 2023-08-03 | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | S - Sale+OE | $11.93 | -44.6K | 627.9K | -7% | -$532.4K |
| DM | 2023-08-02 | 2023-07-31+ | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | M - OptEx | $3.85 | +195.2K | 644.3K | +43% | +$751.4K |
| DM | 2023-08-02 | 2023-07-31+ | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | S - Sale+OE | $11.91 | -195.2K | 627.9K | -24% | -$2.32M |
| DM | 2023-07-27 | 2023-07-25+ | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | S - Sale+OE | $10.91 | -125.5K | 627.9K | -17% | -$1.37M |
| DM | 2023-07-27 | 2023-07-25+ | ROIV | Roivant Sciences Ltd. | Venker Eric | COO | M - OptEx | $3.85 | +125.5K | 656.3K | +24% | +$483.3K |
| DM | 2023-07-24 | 2023-07-20+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | M - OptEx | $3.85 | +374.5K | 677.3K | +124% | +$1.44M |
| DM | 2023-07-24 | 2023-07-20+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $11.19 | -374.5K | 644.2K | -37% | -$4.19M |
| D | 2023-07-24 | 2023-07-24 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $10.99 | -16.3K | 627.9K | -3% | -$179.1K |
| 2023-06-26 | 2023-06-22 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $10.01 | -15.9K | 644.2K | -2% | -$159.0K | |
| DM | 2023-06-09 | 2023-06-07+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $9.91 | -299.6K | 660.1K | -31% | -$2.97M |
| DM | 2023-06-09 | 2023-06-07+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | M - OptEx | $3.85 | +299.6K | 959.5K | +45% | +$1.15M |
| D | 2023-05-25 | 2023-05-23 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $9.58 | -15.7K | 660.1K | -2% | -$150.1K |
| D | 2023-05-25 | 2023-05-23 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $9.85 | -415 | 675.8K | -0.1% | -$4,088 |
| D | 2023-05-25 | 2023-05-23 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | M - OptEx | $3.85 | +415 | 676.2K | +0.1% | +$1,598 |
| D | 2023-05-11 | 2023-05-09 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $9.23 | -238.7K | 675.8K | -26% | -$2.20M |
| D | 2023-05-11 | 2023-05-09 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | M - OptEx | $3.85 | +238.7K | 914.5K | +35% | +$919.1K |
| DMT | 2023-05-08 | 2023-05-04+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $8.56 | -150.0K | 675.8K | -18% | -$1.28M |
| DMT | 2023-05-08 | 2023-05-04+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | M - OptEx | $3.85 | +150.0K | 764.6K | +24% | +$577.7K |
| DMT | 2023-05-03 | 2023-05-01+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $8.40 | -289.0K | 675.8K | -30% | -$2.43M |
| DMT | 2023-05-03 | 2023-05-01+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | M - OptEx | $3.85 | +289.0K | 784.8K | +58% | +$1.11M |
| DMT | 2023-04-28 | 2023-04-26+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale+OE | $8.55 | -222.2K | 675.8K | -25% | -$1.90M |
| DMT | 2023-04-28 | 2023-04-26+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | M - OptEx | $3.85 | +222.2K | 748.7K | +42% | +$855.6K |
| 2023-04-24 | 2023-04-20 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | F - Tax | $8.80 | -14.5K | 675.8K | -2% | -$127.2K | |
| 2023-03-27 | 2023-03-23 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $7.30 | -14.2K | 690.2K | -2% | -$103.6K | |
| 2023-02-24 | 2023-02-22 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $8.43 | -12.0K | 704.4K | -2% | -$100.8K | |
| 2023-01-26 | 2023-01-24 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $8.56 | -13.1K | 716.4K | -2% | -$111.8K | |
| 2023-01-06 | 2023-01-05 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $8.02 | -24.0K | 729.4K | -3% | -$192.8K | |
| M | 2023-01-04 | 2022-12-30+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $7.46 | -119.2K | 753.5K | -14% | -$889.0K |
| 2022-12-28 | 2022-12-23 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $7.10 | -16.0K | 901.6K | -2% | -$113.8K | |
| M | 2022-12-09 | 2022-12-08+ | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $7.03 | -145.1K | 888.7K | -14% | -$1.02M |
| 2022-11-22 | 2022-11-20 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | J - Other | $5.00 | -16.0K | 1.03M | -2% | -$80.0K | |
| 2022-10-27 | 2022-10-25 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $4.40 | -15.9K | 1.05M | -1% | -$70.1K | |
| 2022-09-27 | 2022-09-23 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $3.07 | -17.4K | 1.07M | -2% | -$53.4K | |
| 2022-08-26 | 2022-08-24 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $3.71 | -16.5K | 1.08M | -2% | -$61.3K | |
| 2022-07-27 | 2022-07-25 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $4.33 | -16.9K | 1.10M | -2% | -$73.2K | |
| 2022-06-27 | 2022-06-23 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $4.34 | -16.4K | 1.12M | -1% | -$71.2K | |
| 2022-05-24 | 2022-05-20 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $3.70 | -136.4K | 1.13M | -11% | -$504.8K | |
| 2022-04-27 | 2022-04-25 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $3.84 | -5,107 | 1.27M | -0.4% | -$19.6K | |
| 2022-04-01 | 2022-03-30 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | F - Tax | $4.74 | -15.1K | 1.27M | -1% | -$71.5K | |
| 2022-04-01 | 2022-03-30 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $4.84 | -19.3K | 1.29M | -1% | -$93.6K | |
| 2022-03-29 | 2022-03-25 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, COO | S - Sale | $5.06 | -80.0K | 1.31M | -6% | -$405.0K |
Purchase Sale Sale after option exercise All abbreviations